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1. Introduction  
Post-transcriptional modifications of proteins by ubiquitin and ubiquitin-like proteins 
(UBLs) such as SUMO (Small Ubiquitin-related Modifier) regulate the function of protein-
networks, enable cells to respond to signaling cues during development and to cope with 
the changing environment during adult life. The ubiquitin and SUMO pathways have 
profound impacts on protein stability, localization, protein-protein interactions and 
function.  
In this chapter we will review mechanistic and biological aspects of protein-protein 
interactions that are regulated by ubiquitin and SUMO. We will describe the covalent 
tagging of proteins by ubiquitin and SUMO, and the enzymatic machineries that regulate 
these modifications. Subsequently, we will discuss how ubiquitylated or SUMOylated 
proteins are recognized by ubiquitin and SUMO recognition motifs present on interacting 
proteins. We will also illuminate how these non-covalent interactions regulate diverse 
cellular processes such as DNA repair, transcription, signaling, and autophagy in health and 
disease. Finally, we will address the crosstalk between the ubiquitin and SUMO pathways 
by SUMO-Targeted Ubiquitin Ligases (STUbLs). 
2. Covalent modification of proteins by ubiquitin and SUMO 
Ubiquitylation is a post-transcriptional modification where ubiquitin, a 76 amino acids long 
polypeptide, is covalently attached to proteins. Originally, ubiquitylation was considered as 
a “death-tag” targeting proteins for degradation by the 26S proteasome. However, over the 
last two decades non-proteolytic roles of ubiquitylation have also been found to impact 
protein function, cellular localization and protein-protein interactions. Furthermore, in 
addition to ubiquitin, ubiquitin-like proteins were identified and collectively termed UBLs. 
These proteins include among others SUMO (Small Ubiquitin Like Modifier), Nedd8 
(Neural precursor cell expressed developmentally down-regulated 8), ISG15 (interferon 
stimulated gene 15) and FAT10, and all share at least one of the ubiquitin canonical folds 
(Hershko, 1983; Hochstrasser, 2009). 
Among UBLs, the most studied modifier is SUMO. Vertebrates possess four different SUMO 
isoforms, termed SUMO1-4. While SUMO1-3 are efficiently conjugated to target proteins by 
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specific SUMO enzymes, it is less clear if SUMO4 is conjugated to proteins in vivo. SUMO 
conjugation of target proteins results in a change in their activity, affecting protein 
localization, and modulates composition of protein complexes. In some cases SUMOylation 
may act as a priming modification that promotes ubiquitylation via a specific  specialized 
sub-type of E3 ubiquitin ligases termed SUMO-Targeted Ubiquitin Ligases (Abed et al., 
2011b; Praefcke et al., 2011). Within the scope of this chapter we will focus solely on the 
interactions mediated by ubiquitin and SUMO. 
2.1 SUMO and Ubiquitin pathways  
Ubiquitylation or SUMOylation are both mediated by a tripartite enzymatic cascade 
comprised of specific sets of enzymes. Ubiquitylation is mediated by the E1 ubiquitin-
activating enzyme, E2-ubiquitin-conjugating enzyme (Ubc), and an E3 ubiquitin ligase 
(Hershko 1983; Pickart 2001). SUMOylation is similarly carried out by a different set of 
specialized SUMO specific E1, E2 and E3 enzymes. Both Ubiquitin and SUMO are 
covalently conjugated via their C-terminus Gly residue to free NH2 amine group of the 
target protein that may reside on the ε-amino group of a Lys residue along the protein 
sequence, or on the amino terminus of the protein. Post-transcriptional regulation by 
ubiquitin and UBLs are tightly regulated, as covalent modification by ubiquitin or SUMO 
requires ATP. In the human genome only two genes coding for E1, ubiquitin-activating 
enzymes have been found. It is estimated that about one hundred E2s (ubiquitin-activating 
enzymes), and hundreds or more E3 ubiquitin-protein ligases exist. Interestingly, in plants 
the ubiquitin and SUMO pathways are greatly expanded. Collectively, these observations 
probably reflect the high degree of specificity and regulatory role of these pathways 
(Hershko & Ciechanover, 1998; Weissman et al., 2011).  
E3 ligases are the “match makers” that directly recognize the targeted protein substrate. 
Ubiquitin E3 ligases can be classified into two main functional classes. The first is the HECT 
(Homologous to the E6-AP Carboxyl Terminus) domain ligases that accept ubiquitin from 
an E2 enzyme in the form of a thio-ester via a Cys residue in their catalytic domain, thus 
forming a thio-ester bond directly with the ubiquitin molecule. The second and most 
abundant class is the RING (Really Interesting New Gene) finger E3 ligases which utilizes a 
metal binding domain harbouring Zn+2 ions to facilitate ubiquitylation (Deshaies & 
Joazeiro, 2009). RING ligases are a diverse subclass, encompassing several hundreds of 
proteins in the human genome. This large family of ligases is further divided into modular 
sub-classes: 1. Single subunit ligases such as c-Cbl and parkin, that directly bind to both the 
E2 enzymes and the targeted ubiquitylation protein substrate, and 2. RING E3 ligases that 
function as a multi-protein-complex that recruits substrates via separate subunits. Examples 
for this subclass are the well-characterized APC/C (Anaphase promoting complex; McLean 
et al., 2011) and, the Cullin-based RING E3 ligases (SCF). A subclass of RING-like ligases is 
the U-box ligases, that contain a modified RING motif lacking canonical cysteine residues 
for Zn2+ coordination (Hindley et al., 2001, Patterson, 2002). 
While only one ubiquitin isoform exists, three functional SUMO isoforms have been 
characterized: SUMO1 and SUMO2/3 that share 97% sequence identity. SUMO pathway 
components are much less diverse, comprising of only one known E2 conjugating enzyme 
termed Ubc9 and a few known E3 ligases. A key difference between SUMO1 and SUMO2/3 
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is the lack of a SUMOylation motif in SUMO1. Therefore, SUMO2/3 can form high 
molecular weight SUMO polymers with greater affinity than SUMO1. Similarly to ubiquitin 
ligation, SUMOylation is mostly facilitated via one of two main mechanisms: by recruiting 
an E2-SUMO to the substrate or by enhancing the conjugation of SUMO to a substrate 
already bound to the E2 (Ulrich, 2009). Like E3 ubiquitin ligases, SUMO E3 ligases are 
diverse and have been categorized into three families. The first class is PIAS like (Protein 
Inhibitor of Activated STAT–signal transducer and activator of transcription) proteins which 
posses an SP-RING domain functioning similarly to the ubiquitin RING domain and 
interacting with Ubc9. The second class is the RanBP2/Nup358 (Nuclear pore proteins Ran 
binding protein 2 and nucleoporin 358) like proteins, which harbour tandem elements that 
are capable of binding both Ubc9 and SUMO. A third group includes proteins like polycomb 
group protein Pc2, TOPORS (Topoisomerase I-binding RING finger protein) and likely 
HDAC4 (histone deacetylase 4) whose molecular mechanism of SUMO ligation is not fully 
understood (Gareau & Lima, 2010; Hannoun et al., 2010).  
2.1.1 Mono ubiquitylation and SUMOylation 
Mono-ubiquitylation is formed in most cases by a covalent attachment of the carboxy 
terminal glycine of the ubiquitin polypeptide to the ε-amino group within the side chain of 
Lys residues on the target protein. In some cases the attachment site could be the free NH2-
group of the protein’s first amino acid. Mono-ubiquitylation or mono-SUMOylation are 
mediated by ubiquitin-conjugating enzymes (Ubcs, E2s) or in the case of SUMO by the 
single SUMO conjugating enzyme, Ubc9. A single protein can be modified by several mono-
ubiquitin monomers, resulting in multi-mono-ubiquitylation.  
Mono-ubiquitylation most commonly has a regulatory function as a cellular signal, marking 
transmembrane receptors for recycling in the lysosome, or alternatively marking specific 
histone tails, thereby impacting chromatin structure. Yet, it can also serve as a degradation 
signal. As for SUMO, the three SUMO isoforms differ in their conjugation ability, but all 
three forms can be conjugated to form mono-SUMOylated substrates. Like ubiquitin, SUMO 
is bound to the target protein via a covalent attachment of its C-terminal carboxyl group to 
the ε-amino group on the Lys residue of the modified protein. Subsequently, SUMOylated 
and ubiquitylated proteins are recognized by a specific interaction motif that functions as a 
‘receptor’ for these proteins on their interaction partners. In both cases multiple Lys residues 
within the target substrate can undergo ubiquitin/UBL modifications, generating multi-
ubiquitylated or SUMOylated proteins (Hurley, 2006; Gareau & Lima, 2010).  
2.1.2 Poly ubiquitylation and SUMOylation 
Successive rounds of ubiquitylation or SUMOylation of a single covalently attached mono-
ubiquitin or mono-SUMO molecules will generate poly-ubiquitin or poly-SUMO chains. 
Ubiquitin- or SUMO-protein ligase enzymes (E3), together with distinct E2s are essential for 
catalyzing poly-ubiquitylation, SUMOylation, and determine substrate specificity as well as 
govern chain structure. Following mono-ubiquitiylation, E2 and E3 ligases conjugate 
subsequent ubiquitin units, forming additional iso-peptide bonds between the carboxyl group 
of the newly added ubiquitin molecule and the ε-amino group of the Lys residue of the 
already covalently attached ubiquitin molecule. Recent work suggests that these chains serve 
www.intechopen.com
 
Protein Interactions 56
as a versatile “code” that regulates protein fate, and that the internal structure and length of 
the chain directly impacts its recognition by “reader” proteins (Weismann et al., 2011).  
Poly-ubiquitylation may be linked through any of the seven Lys residues present in the 
ubiquitin molecule - Lys6, Lys11, Lys27, Lys29, Lys33, Lys48 and Lys63 or the ubiquitin N-terminal 
Met (Met1). Additional ubiquitin chains can be linked through the same Lys residue within 
ubiquitin, forming homotypic chains. One unique form are linear poly-ubiquitin chains where 
the C-terminal Gly of the ubiquitin molecule is sequentially linked to the N-terminal Met of the 
next ubiquitin molecule. In addition, chains linked through different Lys side chains can form 
mixed poly-ubiquitin chains (i.e. harbouring alternating Lys linkage types) or even branched 
trees of ubiquitin molecules in which more than one Lys residue is extended. Thus, while only 
one isoform of ubiquitin exists, diverse arrays of ubiquitin chains are formed, dictating 
different globular structures. Aside from the role in proteasomal degradation mediated by 
chains with a Lys48 linkage, other types of poly-ubiquitylation chains regulate protein-protein 
interactions in processes such as DNA repair or immune signalling. For example, linear poly-
ubiquitin chains are important for the regulation of NFκB signalling (as shortly described 
below, and Harper & Schulman, 2006; Ikeda & Dikic, 2008; Iwai & Tokunaga, 2009; Weismann 
et al., 2011; Kim et al., 2011; Behrends & Harper, 2011).  
K63-linked ubiquitin chains have been reported to function as scaffolds for the recruitment 
of other signaling proteins upon cytokine stimulation, and recently an emerging unique role 
for ubiquitin conjugation in TNF-R signaling was characterized. TNF receptor-1 (TNF-R) 
activation results in K63-linked ubiquitin chains. These chains are specifically generated by 
two ubiquitin RING E3 ligases named Haeme-Oxidized-IRP2-ubiquitin-Ligase-1 (HOIL-1) 
and Haeme-Oxidized-IRP2-ubiquitin-Ligase-1-Interacting-Protein (HOIP). HOIL-1 and 
HOIP along with a third protein, SHARPIN, form the linear ubiquitin chain assembly 
complex (LUBAC) that catalyzes linear head-to-tail ubiquitylation by ligating the N-terminal 
Met1 residue of the ubiquitin molecule to the C-terminal Gly residue of another ubiquitin 
molecule. TNF- induced LUBAC complex binds to an activator of the NFκB pathway named 
NFκB Essential Modifier (NEMO). LUBAC conjugates linear poly-ubiquitin chains to 
NEMO and enhances the interaction between NEMO and the TNF-R signaling complex. 
Since NEMO is required for efficient activation of the TNF-R signaling complex, LUBAC 
activity influences activation of the NFκB pathway. Taken together, linear ubiquitylation in 
this case serves as a survival machinery required for the proper activation of the TNF-R 
signaling complex, NFκB gene induction, and protection from TNF-induced cell death (Haas 
et al., 2009; Gerlech et al., 2011; Iwai, 2011; Niu et al., 2011). 
As for SUMO, three SUMO1-3 genes encode for proteins that differ from one another in 
their ability to form SUMO chains. Only SUMO2/3 possess a Lys residue within a 
consensus motif ΨKXE that facilitates the formation of SUMO chains. SUMO-1 lacks this 
consensus site and therefore formation of poly-SUMO chains is less favorable. Yet, in vitro it 
can form polymeric chains and can serve as the chain terminator of SUMO chains. Of the 
eight Lys residues encoded in the SUMO molecule, SUMO chains are predominantly 
formed via Lys11. SUMOylation of proteins was thought to enhance transcriptional 
repression; however, new findings suggest a more diverse function for SUMOylation. 
SUMOylation was found to affect sub-cellular localization and is also involved in intra-
nuclear localization, transport and apoptosis, as well as in targeting proteins for ubiquitin-
mediated degradation (Ulrich 2008; Matic et al., 2008; Ulrich, 2009).  
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2.1.3 Ubiquitin and SUMO chain editing 
Covalent ubiquitylation or SUMOylation is a reversible process in which de-ubiquitylating 
enzymes (DUBs) or sentrins/SUMO specific proteases (SENPs), promote the cleavage of the 
iso-peptide bond and release ubiquitin or SUMO molecules, respectively. About 80 known 
DUBs, and less than 10 SENPs, are devoted to removing covalent ubiquitin or SUMO 
modifications. DUBs serve to perform three distinct roles in the cell; First, DUBs can cleave 
some of the ubiquitin molecules that are transcribed as a linear fusion chain for future 
conjugation processes. Second, DUBs mediate the removal of ubiquitin from tagged proteins 
prior to their degradation, allowing for recycling of ubiquitin molecules for future 
conjugation processes. Third, DUBs can trim ubiquitin chains, subsequently changing their 
length and structure (Komander, et al., 2009a). Editing of ubiquitin chains by specific 
ubiquitin peptidases may impact their recognition by the proteasome, or affect protein-
protein interaction. Interaction between DUBs and ubiquitylated proteins is mediated 
through ubiquitin interacting motifs within the DUBs (UIMs and UBD, ubiquitin binding 
domains, see below and chapter 3.1.1). DUB-mediated chain editing is essential for 
regulation of chromatin structure, and is involved in DNA damage repair pathways as well 
as endosomal targeting of membrane bound receptors (Katz, 2010).  
One of the well-studied DUBs is the tumor suppressor CYLD (cylindromatosis associated 
DUB). CYLD is a negative regulator of Wnt, NFκB and JNK signaling pathways in immunity 
and inflammation. Among CYLD's targets are substrates with Lys63-linkage ubiquitylation 
chains like TRAF6, BCL3, PLK1 that regulate cell cycle proliferation and apoptosis 
(Massoumi, 2010). CYLD also forms a protein complex with the ubiquitin ligase Itch. 
Together this editing complex inhibits TAK1, which is required for termination of the 
immune response (Wertz, 2011). Importantly, mutations in CYLD are associated with 
cylindromatosis, a predisposition to benign tumors of the hair follicle in the skin and other 
secretory glands. Another  work established that CYLD functions as a tumor suppressor and 
its loss is associated with cancer (Bignell et al., 2000). In this regard, DUBs are emerging as 
excellent targets for small molecule inhibitors. For example, recent work from the Dixit 
group revealed that genetically or chemically targeting USP1 induces muscle stem-cell 
differentiation, and can serve as a molecular target for therapy of osteosarcoma that is 
highly resistant to conventional chemotherapy (Williams, 2011).  
Like ubiquitiylation, SUMOylation is also a reversible process, and a family of seven sentrin-
specific proteases (SENPs) catalyzes de-SUMOylation. Family members differ from one 
another based on SUMO chain specificity and cellular localization that is determined by 
distinct N-terminal domains. Biochemical and genetic experiments revealed that SENPs 
show high degrees of specificity. Towards example, the SENP6 and SENP7 have greater 
affinity de-conjugation of di- and poly-SUMO2/3 chains than SUMO1 (Lima & Reverter, 
2008). SENPs harbor a Ulp domain at their C-terminus which facilitates the cleavage of the 
isopeptidic bond between the SUMO molecule and the Lys group on the modified protein. 
SENP-mediated de-conjugation plays an important role in the regulation of developmental 
and signaling processes. It is also important for tightly regulating the levels of free SUMO in 
the cell. The regulatory function of SENPs is biologically relevant in development. SENP3/5 
are required for ribosomal biogenesis, and targeting SENP2 during cardiac development 
impairs the expression of key cardiac factors Gata2 and Gata6 (Yun et al, 2008; Kang et al., 
2010). Specifically, in SENP2 null embryos, SUMOylated polycomb group Pc2/CBX4 
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complex accumulates on the promoters of PcG target genes, leading to repression of Gata4 
and Gata6 transcription. SENPs also play a key role in tumorigenesis; expression of SENP1 
transforms prostate cancer cells and activates Androgen Receptor (AR) signaling. In 
addition, SENP3 regulates angiogenesis via its impact on HIF1α-associated coactivator p300, 
and elevated mRNA levels of SENP6, 7 are linked to breast cancer (Cheng, 2010; Bawa-
Khalfe & Yeh, 2010).  
3. Recognition motifs for ubiquitin and SUMO ligases 
Are there preferred (consensus) sites for ubiquitylation? While recognition motifs for 
recruitment of ubiquitin ligases (“Degrons”) exist, it appears that site-specific ubiquitylation 
is more promiscuous. This variability may stem from the different structural requirements 
for the diverse interactions of heterogeneous substrates with a variety of E2-E3 complexes. 
In contrast, the acceptor Lys residues in many SUMOylated proteins reside within a 
consensus motif ΨKXE (Ψ- hydrophobic residue; X, any amino acids; E, glutamic or 
aspartic), forming a unique conformation, which interacts directly with the specific 
hydrophobic groove on the Ubc9 enzyme. In addition to the canonical SUMOylation 
consensus sequence, longer consensus sequences with specific characteristics have been 
identified. Among them are the inverted form of the canonical sequence, a hydrophobic 
cluster motif enriched with a consecutive sequence of large hydrophobic residues, a 
phosphorylation dependent motif – PSDM (ΨKXEXXSP) and a negatively charged amino-
acid motif - NDSM (ΨKXEXXEEEE). The existence of this highly characterized consensus 
motif correlates with to the existence of a single unique E2-SUMO conjugating enzyme. Yet, 
some proteins can be SUMOylated without the presence of the characterized consensus 
sequence (Ulrich, 2009). 
3.1 Recognition of ubiquitylated and SUMOylated proteins  
Regardless of the final fate of the modified proteins, covalent tagging by ubiquitin or SUMO 
is “sensed” by protein motifs that subsequently mediate protein-protein interactions 
involved in numerous cellular processes. In this section we will discuss the currently known 
domains that recognize mono and poly-ubiquitin/UBL chains. While our understanding of 
these interactions is in its infancy, it is the focus of intensive research. For simplicity we will 
focus on “sensing “ ubiquitin and SUMO monomers and polymers.  
Proteins modified by ubiquitylation or SUMOylation interact non-covalently with other 
proteins via ubiquitin binding domains (UBD), or SUMO interacting motifs (SIM), 
respectively. These motifs are present in many proteins and thereby mediate multiple 
interactions, and have the potential to induce conformational changes and to impact the 
avidity of existing protein complexes or to form new protein complexes (see Fig 1).  
3.2 Ubiquitin binding domains 
UBDs are motifs that enable the association of proteins with either mono ubiquitin or 
ubiquitin polymers. More than 20 domains have already been identified, and more than 150 
different human proteins harbor a versatile combinations of UBDs. Most UBDs interact with 
ubiquitylated proteins via a hydrophobic patch that include Leu8, Ile44 and Val44 within 
the ubiquitin molecule on one hand, and a α-helix motif of the UBD on the other hand. 
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Intensive structure analysis identified that UBD includes, among others, zinc finger 
interacting domains (ZnF/PAZ/UBZ), plekstrin homology fold (PH fold), and ubiquitin 
association domain (UBA) as well as ubiquitin-conjugating-like domains (Dikic et al., 2009).  
 
Fig. 1. Regulation of protein-protein interactions by Ub/SUMO signalling  
(A). Mono-ubiquitin or mono-SUMO modified substrates are recognized by Ubiquitin 
Interacting Motif (UIM/UBDs), or by SUMO interacting motifs (SIMs). (B). Poly-ubiquitin or 
poly-SUMO chains can mediate interaction with several proteins in tandem, or with a single 
protein harboring several UIM/SIM domains. (C). Combinatorial modifications by mono 
ubiquitin or SUMO can be sensed by multiple proteins each harboring a discrete interaction 
motif, or via multiple domains within a single protein. (D-E). Similar to mono ubiquitylation 
and SUMOylation, modification by UB/SUMO mixed-chains can be recognized by  multiple 
domains either within a single protein (D), or in the context of several proteins within a 
protein complex (E).  
Different UBDs recognize and interact with different ubiquitin polymers. Some UBDs bind 
specifically to mono-ubiquitylated proteins. For example the mammalian Eap45 subunit of 
the endosomal sorting complex harbors a UBD domain termed GLUE domain that interacts 
with the hydrophobic patch of the ubiquitin molecule (Hirano et al., 2006).  
Interestingly, the classical α-helix ubiquitin-interacting motif UIM, such as the one that is 
present in the proteasome S5a subunit and yeast Rpn10 as well as RAP80, can be found in 
some cases in an “inverted” orientation to form “inverted UIM” (IUIM/MIU). In most cases, 
each UBD interacts with a single ubiquitin molecule. Yet, ZnF binding domains, such as the 
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one found in the guanine nucleotide exchange factor RABEX; interact with multiple surfaces 
on ubiquitin. Hence, in this case a single ubiquitin molecule can interact with three ZnF 
motifs simultaneously (Penengo et al., 2006). Tandem repeats of UBDs may dictate chain 
specific interaction. For example, RAP80, which is recruited together with BRCA1 to 
damage sites, harbors two adjacent UIMs that binds Lys63 but not of Lys48 Linked-poly-
ubiquitin chains (Hicke et al., 2005; Harper & Schulman, 2006; Komander 2009b; Dikic et al. 
2009). In contrast, the ubiquitin receptor RAD23A, that is required for targeting proteins to 
the proteasome, has a C-terminal UBA domain. RAD23 UBA domain has a 6.3 fold higher 
affinity to Lys48 than to Lys63 chains and a 70 fold higher affinity to Lys48 chains than to free 
ubiquitin (Raasi et al., 2005).  
The specificity of different UBDs toward chain linkage is greatly dependent on UBDs 
present in DUBs. For example, while isoT is dedicated for the de-conjugation of Lys48 chains, 
CYLD is specific for Lys63. Recently a novel UBD that recognizes linear poly-ubiquitin 
chains (UBAN) was characterized. Importantly, the ability of a cell to respond to TNFα and 
to activate the IKK kinase complex is compromised in cells that have a mutated UBAN 
domain within the NEMO protein that is required for activation of the IKK complex 
(Rahighi et al., 2009; Lo et al., 2009). Likewise, recent work has shown that the ESCRT 
sorting complex that is involved in targeting the EGF receptor for lysosomal degradation is 
based on a combination of various UBDs on different ubiquitin receptors. Together these 
ubiquitin receptors form a large protein complex harboring a high avidity interaction 
surface with an ubiquitylated cargo (Raiborg & Stenmark, 2009).  
An interesting case where binding to ubiquitin chains via ubiquitin receptors plays a key 
role is autophagy. Autophagy is used by macrophages as a defense mechanism against 
infection by invading intracellular bacteria. A molecular link between autophagy and 
ubiquitylation was established following the identification of autophagy receptors, which 
simultaneously bind both ubiquitin and autophagy-specific ubiquitin-like modifiers 
(Atg8). Several ubiquitin-related autophagy pathways have already been characterized 
such as the ubiquitin-NDP52-LC3 pathway, which targets group-A-Streptococcus, 
Salmonella typhimurium, or the ubiquitin-p62-LC3 pathway, which targets Mycobacterium 
tuberculosis and Listeria monocytogenes. Listeria is a  gram-positive pathogen that expresses 
several virulence proteins including a hemolysin (listeriolysin O, LLO). LLO bacterial 
proteins in macrophages infected with Listeria were found to form small aggregates 
associated with poly-ubiquitin chains and to undergo selective autophagy by the p62-LC3 
pathway (Ogawa et al., 2011). A recent report determined that targeting the SUMO 
conjugating E2, Ubc9, for degradation and subsequently inhibiting SUMOylation mediate 
part of the virulence of Listeria. Furthermore the Dikic lab recently showed that invading 
Salmonella are coated with poly-ubiquitin chains ligated by a yet to be identified ligase. 
Subsequently, the ubiquitin chain binding proteins p62 and NDP52 bind to the poly-
ubiquitin chains and recruit the protein Optineurin (OPTN) that upon its phosphorylation 
by Tank Binding Kinase (TBK) connects the coated pathogen to LC3 autophagy receptors 
allowing the engulfment and autophagy of the pathogen. Thus, an emerging network of 
interactions between the SUMO pathway, ubiquitin chains, ubiquitin binding proteins and 
ubiquitin like proteins (Atg8) plays a key role in elimination of bacteria and innate 
immunity (Wild et al., 2011; Weidberg et al., 2011). 
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3.3 SUMO interacting motifs  
In analogy to ubiquitylation, SUMOylation is also “sensed” by a specific protein motif, 
termed SUMO Interacting Motif (SIM). SIM motifs are characterized by a sequence motif of 
hydrophobic amino acids (V/I) X (V/I) (V/I). The SIM domain interacts with the 
hydrophobic patch on SUMO. This hydrophobic interaction is re-enforced with other weak 
non-covalent interactions that are formed between basic residues on the SUMO and the 
acidic residues flanking the SIM domain (Gareau & Lima, 2010). SIM–mediated recruitment 
plays a key role in transcriptional repression. SUMO/SIM-mediated binding is required for 
the recruitment of histone de-acetylases and histone de-methylases to co-repressor 
complexes, as well as impacts the activities of chromatin remodeling factors. Examples for 
these interactions are the SIM/SUMO dependent recruitment of HDAC2 to SUMOylated 
Elk2, and the SUMO2/3 and SIM dependent recruitment of the Lys demethylase (LSD) to 
the CoRest co-repressor complex. In this case, CoREST1 binds directly and non-covalently 
SUMOylated REST (NRSF) to bridge HDAC2 and LSD (Yang & Sharrocks, 2004; Gill, 2005; 
Ouyang & Gill, 2009). Furthermore, SUMO/SIM interactions are likely to impact 
nucleosome remodeling as the recruitment of the ATP-remodeling complex protein Mi-2 to 
the transcription factor SP3 is SIM/SUMO dependent (Stielow et al., 2006).  
SIMs and UBDs are targets for posttranscriptional modification (PTMs). These PTMs impact 
the structural properties of SIMs, UBDs or their immediate vicinity, resulting in a change in 
the binding properties of the modified domains. For example a CKII-mediated 
phosphorylation site near the SIM domain in the co-repressor DAXX shifts specificity 
between SUMO prologs. The DAXX (Fas death domain associated protein) is a 
transcriptional co-repressor that binds to a variety of transcription factors at the promoter 
sites of anti-apoptotic genes. The SIM domain within DAXX facilitates a non-covalent 
interaction with other SUMOylated proteins. DAXX binding to SUMO-1 but not SUMO2/3 
is enhanced by CKII phosphorylation of DAXX Ser737, 739 surrounding its SIM domain, 
enhancing its recruitment and subsequent transcriptional repression of these anti-apoptotic 
genes (Chang et al., 2011; Mukhopadhyay & Matunis 2011). Thus, the observations that 
SIMs and likely UBDs are targeted to PTMs by signaling pathways provide evidence for 
another layer of regulation that establish a direct crosstalk between signaling pathways and 
ubiquitin/SUMO signals.  
4. Cross talk between ubiquitylation, SUMOylation, and the function of 
SUMO-targeted ubiquitin ligases 
While both ubiquitin and SUMO pathways have been well studied individually, the long-
speculated nature of the crosstalk between SUMO and ubiquitin pathways has been 
molecularly enigmatic. Importantly the interplay between SUMOylation and ubiquitylation 
can be a critical determinant in signaling, transcription, and cancer (Karscher 2006). For 
example, the equilibrium between SUMOylation and ubiquitylation can influence the 
balance between p53 nuclear localization and stabilization, cytoplasmic export and 
degradation, as well as regulating the activity and stability of Hypoxia Induced Factor (HIF; 
Lee et al., 2006; Carter et al., 2007; Carbia-Nagashima et al., 2007).  
The crosstalk between Ubiquitin and SUMO is mediated at several levels. First, 
SUMOylation or ubiquitylation on the same Lys residue can differentially regulate the 
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activity and fate of several proteins. For example, ubiquitylation of Lys164 of the Proliferating 
Small Nuclear Antigen (PCNA), which is required for replication and DNA damage 
response, enhances the recruitment of translesion error-prone DNA polymerases. Yet, 
genetic evidence suggests that SUMOylation at this site by the SUMO ligase Siz-1 at S-phase 
promotes PCNA association with the Srs2 helicase and restricts the helicase activity (Bergink 
& Jentch 2009). Second, enzymes within each pathway are targets for modification by the 
other pathway. For example, the ubiquitin ligase E2-25k undergoes SUMOylation at its core 
domain that inhibits its activity. Another example is the DUB USP25 that is regulated by 
both SUMOylation and ubiquitylation. In this case SUMOylation inhibits its function, and 
ubiquitylation at the same site enhances its enzymatic activity. An interesting case is the 
ubiquitin/SUMO ligase TOPORS. TOPORS is unique as it can catalyze the formation of 
either ubiquitin or SUMO chains. Importantly, a phospho-switch induced by the polo like 
kinase, PLK1 results site-specific phosphorylation of TOPORS, inhibiting its ability to 
SUMOylate, but enhancing its ubiquitylation activity (Yang et al., 2009). 
However, until recently it was not clear how does the cell directly “sense” and integrate the 
ubiquitin and SUMO signals at the single protein level. A first direct and enzymatic link 
between the two pathways was established by the identification of SUMO-targeted ubiquitin 
ligases (STUbLs). STUbLs are a unique group of RING proteins: they bind non-covalently to 
the SUMO moiety of SUMOylated proteins via several SIM motifs, and subsequently target 
the SUMOylated protein for ubiquitylation via a RING domain [Sun et al., 2007; Geoffroy 
&Hay, 2009; Abed et al 2011b]. STUbLs impact protein stability, localization, and are required 
for the maintenance of genomic integrity, transcription and are involved cancer. Thus, STUbLs 
integrate the SUMO and ubiquitin pathway and generate a SUMO/ubiquitin dual signal that 
may serve as an additional level of regulation of protein-protein interactions.  
 
Fig. 2. Classical mode of action of STUbL: STUbL interact with SUMOylated-proteins via its 
SUMO Interacting Motifs (SIM). Subsequently, dimers of STUbL proteins interact with 
charged E2 –Ub complex, and catalyze poly-ubiquitylation via the RING domain.  
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4.1 Characterization of STUbL proteins 
STUbLs are highly conserved in eukaryotes. Members of the STUbL family include for 
example: the yeast S. pombe Slx8-Rfp; S. cerevisiae Slx5–Slx8; H. sapiens RNF4; D. discoideum 
MIP1; and the D. melanogaster Degringolade (Dgrn). Yet, no clear STUbL orthologs exist in 
the worm C. elegans. These members are structurally and functionally conserved, as RNF4 
protein can substitute for the yeast and fly genes in functional assays (Abed et al., 2011a 
Abed et al, 2011b; Barry et al., 2011; Praefcke et al., 2011). Recent structural work from the 
Hay lab uncovered that RNF4, and likely other STUbLs, function as dimers and that dimer 
formation is actively required to facilitate SUMO-dependent ubiquitin conjugation 
(Plechanovova’ et al. 2011). 
Several observations link STUBLs to protein degradation: 1. STUbLs bind and ubiquitylate 
SUMO chains, 2. STUbLs enhance the degradation of SUMOylated proteins 3. Genetic 
ablation of STUbL genes in yeast, flies, and cancer cells results in accumulation of poly-
SUMOylated proteins. Among the most studied substrates of RNF4 are the promyelocytic 
leukaemia protein, PML and its derived oncogene PML-RAR. An elegant set of experiments 
by several groups established that arsenic-induced phosphorylation enhances poly 
SUMOylation of PML and recruitment of RNF4. Subsequently, RNF4-dependent 
ubiquitylation targets SUMOylated and ubiquitylated PML for degradation via the 26S 
proteasome (Lallemand-Breitenbach et al., 2008; Tathem et al., 2008). This is highly relevant 
to the treatment of acute promyelocytic leukemia, where a combination of Retinoic Acid 
(RA) with arsenic treatment can result in 90% cure (Lallemand, 2011). Other bona-fide 
human substrates of RNF4 are the kinetochore proteins CENP-I and VHL. In addition, 
proteomic analysis using RNF4 as a bait identified a wide spectrum of proteins that are 
bound by RNF4 (Makhopadhyay et al., 2010; Tatham et al., 2011). While the exact nature of 
these interactions requires further characterization, GO analysis already points out that 
SUMO-dependent ubiquitylation by RNF4 is relevant to a large verity of protein complexes 
and involves diverse cellular process.  
An interesting issue is the recognition of proteins by STUbLs. While by their definition STUbLs 
recognize SUMOylated substrates via their SIM motifs, recent reports suggest a more complex 
picture. For example, the recognition of the Mat2α repressor by Slx5: Slx8 does not require 
substrate SUMOylation, but does require intact SIM motifs (Xia et al., 2010) Furthermore, the 
binding of the Drosophila STUbL Dgrn to the Notch-related HES repressor proteins is 
independent of SUMOylation, and is mediated by Dgrn’s RING domain and not the SIM 
motif. Yet, the SIM motifs are required for ubiquitylation in vitro and for Dgrn’s impact in vivo 
(Abed et al., 2011a, Barry et al., 2011). Thus, it is highly likely that specific interactions are 
determined in vivo by a dual recognition machinery, where the SIM motif interacts with the 
poly-SUMO chain and the RING domain interacts with other non-SUMO determinants in the 
target protein or adjacent proteins. In addition, recent work suggests that RNF4 can interact 
with proteins such as Nip45 that harbour two SUMO Like Domains (SLDs), but are not 
SUMOylated, thus expanding the spectrum of RNF4 targets (Sekiyama et al., 2010). 
4.2 Cellular processes regulated by STUbLs 
STUbLs are required for normal development, for the cell’s ability to cope with genotoxic 
stress, and to maintain genome stability (Prudden et al., 2007; Nagi et al. 2008; Nagi et al., 
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2011and Barry et al., 2011). During mouse development, RNF4 is highly expressed in the 
stem cell compartment of the developing gonads and brain (43). RNF4 was also identified 
as a gene that is specifically expressed in hematopoietic, embryonic, and neural 
progenitor cells, likely representing its role in “stemness” (Galili et al., 2000; Ramalho-
Santos et al., 2002). During early Drosophila development Dgrn localizes to centrosomes, 
and dgrn null embryos accumulate SUMOylated proteins. dgrn null embryos show 
genomic instability phenotypes; they fail to incorporate DNA into centrosomes, assemble 
aberrant mitotic spindles and exhibit chromosomal bridges at anaphase. Cells in dgrn null 
embryos show high SUMO content and fall from the embryo surface into the center of the 
syncytium (Barry et al., 2011). These findings fit well with those reported for the yeast 
STUbLs, as yeast lacking Slx5:Slx8 display genomic instability, and are hypersensitive to 
replication stress. For example, yeast deficient in Slx5: Slx8 fail to replicate DNA upon 
hydroxy-urea treatment (Prudden 2007, Rouse, 2009). While the protein substrates of 
STUbLs in this context are still unknown, the observations that many of the proteins 
involved in the DNA damage response are ubiquitylated, SUMOylated, or contain SLD 
motifs suggest that STUbLs are targeting specific regulatory “nodes” in the DNA response 
network. Since genomic instability is a hallmark of cancer cells, proteins such as STUbLs 
may be the “Achilles heel “ in specific cancerous settings. Therefore we predict that 
STUbLs inhibition will results in collapse of the tumorigenic network and cancer 
elimination.  
Interestingly, and prior to the identification of RNF4 as a dedicated STUbL protein, RNF4 
was identified by the Palvimo lab as a potent transcriptional regulator that functions both 
as a co-activator or a co-repressor depending on the cellular context. For example RNF4 
was shown to be essential for androgen and steroid receptor-mediated target gene 
activation (Moilanen et al., 1998; Poukka et al., 2000;). In addition, we found that in 
transcription the consequences of Dgrn activity are not strictly limited to targeting 
SUMOylated proteins for degradation (Abed et al., 2011a; Barry et al., 2011). Importantly, 
Dgrn/RNF4-mediated ubiquitylation impacts the affinity between proteins, inhibiting the 
interaction of a given protein with one protein but not affecting its ability to bind other 
protein. Specifically, we found that during fly development Dgrn serves as a molecular 
selector that determines co-repressor recruitment as described below. Dgrn-mediated 
ubiquitylation of the HES-related repressor Hairy inhibits its ability to interact with its co-
repressor Groucho but not with other Hairy co-repressors such as dCtBP. In addition, we 
find that Dgrn specifically targets SUMOylated Gro for sequestration. Yet, the exact 
cellular and molecular details surrounding sequestration require further exploration. 
Accordingly, Dgrn antagonize Hairy/Groucho-mediated repression in transcription and 
function in cells and in vivo. Genome wide association studies using DamID profiling 
unveiled that the activity of Dgrn is relevant genome wide. Thus, Dgrn serves as a 
“molecular selector” that determines protein-protein interactions. We found that this 
“selector” activity of Dgrn/RNF4 is likely relevant also to HES independent processes and 
in other types of co-factor switches, and may directly impact chromatin structure (Abed et 
al., 2011a; Hu et al., 2010; Orian unpublished). We speculate that this activity of STUbLs 
will be highly relevant not only in transcription, but in the regulation of protein-protein 
interactions in other cellular process such as the selective recruitment of proteins to DNA 
repair foci. 
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5. Conclusion and future challenges 
We focused on ubiquitin and SUMO signalling as a mode to regulate protein-protein 
interactions. We predict that the lessons learned during the last decades regarding ubiquitin 
and SUMO will be highly relevant for other UBLs and non UBL modifications. An important 
concept that emerges from these studies is that combinatorial posttranscriptional 
modifications by ubiquitin/UBLs serves as a molecular tool to regulate and establish diverse 
and selective, signal-induced protein-protein interactions. Furthermore, proteins that have 
ubiquitin like or SUMO like domains, and the ability of specific enzymes to catalyse different 
and distinct chains of ubiquitin/UBL proteins, further add to this diversity. This complexity is 
also reflected at the level of “reader” proteins that contain several UBD/UBL recognition 
motifs and that bind only a discrete combinatorial ubiquitin/UBL signal. Thus, we can 
envision how a relatively small number of signalling pathways and a limited pool of 
ubiquitin/UBLs can generate discrete protein-protein interactions. We predict that a key 
objective for future studies will be to understand the enzymatic machinery that dictates 
selective recruitment In distinct cellular processes. The identification of these enzymes has 
direct implications beyond basic research. It will pave the way to design highly selective 
inhibitors that will impact specific pathways with minimal side effects, features that are 
desired in the clinic such as in the case of cancer treatments. 
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